Cognistat – a global leader in cognitive health, offers healthcare professionals a rapid non-invasive neurocognitive assessment and screening test used by healthcare professionals to identify cognitive impairments associated with various neurological or psychological conditions such as (but not limited to) depression, and anxiety, dementia, stroke, traumatic brain injury. It quickly assesses cognitive functioning in the five major ability areas: language, spatial skills, memory, calculations, and reasoning.
Cognistat provides a domain specific profile that helps in highlighting the affected area of the brain functions and uses normative data to assist the healthcare provider for the effective selection of further evaluation steps or treatments.
Cognistat allows for alternative delivery and interaction with healthcare providers. In addition, it permits longitudinal comparisons between repeated assessments. These are crucial for enabling healthcare providers to adjust treatment and demonstrate the effectiveness of both treatment and rehabilitation. Additionally, they can use assessment data archives and clinical outcomes to optimize treatment strategies for various disorders.
An integral part of provision of leading-edge care is through the ongoing evolution of patient care through innovation, research and novel thinking in health care.
More than ever, patient care and engagement are evolving through several main concepts; the use and leveraging of technology to advance care, moving towards personalized/precision care, and understanding the biological underpinnings of mental health issues.
With over 400 peer reviewed scientific publications in brain injury, dementia, stroke, and other neurodegenerative disorders Cognistat has demonstrated its validity and reliability.